Confirmed Preliminary Control Closed Transaction verified Supplements

Nutraceutical acquired by HGGC

HGGC acquired Nutraceutical, a vitamins & supplements brand.

Preliminary: The transaction value is not yet independently verified.

Transaction summary

Target
Nutraceutical
Acquirer
HGGC
Seller
-
Announced
2017-05-22
Geography
-
Tags
Supplements
1 more tag
CPG
Type
Acquisition
Deal type
Control
Stake acquired
-
First added
2026-06-19
Latest update
2026-10-31

Value and multiples

100% enterprise value

USD 446M

Unverified

100% enterprise value | USD

Basis: Public source

Reported price is assumed to be 100% EV unless stated otherwise. Partial-stake estimates are qualified in the basis notes.

EV / revenue

1.8x

Period not stated

Basis: FundComb estimate

EV / EBITDA

9.9x

EBITDA basis not stated

Basis: FundComb estimate

Basis

  • The 1.8x revenue and 9.9x EBITDA multiples come from FundComb’s comps spreadsheet and are not confirmed by a public source; the price, revenue, EBITDA and period behind them are not stated. Private Equity Professional reported on 22 May 2017 that HGGC would buy Nutraceutical.

Other reviewed estimates

Earlier estimates and their sources.

Thorne HealthTech Schedule 14D-9/A
EBITDA USD 48.5m | EV / EBITDA 9.2x
Open evidence
Multiples are from pasted VMS spreadsheet row: EBITDA multiple 9.9x and EV/sales multiple 1.8x; no public evidence supplied verifies these metrics.
EV / revenue 1.8x | EV / EBITDA 9.9x

Source summary

HGGC to Buy Nutraceutical - Private Equity Professional

Confirmed
Open via Google News

Thorne HealthTech Schedule 14D-9/A

Estimated

Precedent transaction row lists implied TEV of $446m and TEV/LTM Adjusted EBITDA of 9.2x.

Open source

Continue your research

Explore more comps →